Pharmafile Logo

Beat inflation with virtual meetings and programs

At the time of writing, the average inflation rate worldwide sits at 7.4%, the highest it’s been for decades. Here in Canada, the inflation rate is not forecasted to come back down to “normal” levels until 2024. As a life science service provider working with companies across the world, we are seeing firsthand how some companies are already tightening their budgets in response to the ongoing economic uncertainty and other world events such as the war in Ukraine.

Inflation is impacting all aspects of in-person meetings

After 2+ years of COVID-19-imposed restrictions, many teams are itching to get back to in-person meetings. However, with flightgasoline, and food prices skyrocketing lately, in-person engagements are becoming more expensive and may not be the best “bang for your buck.” (That is, if your advisors and team members can even make it to the meeting on time amidst record flight cancellations and delays.)

The good news is that there are ways to beat inflation and still continue those vital engagements with your key stakeholders. Instead of relying only or mainly on in-person meetings for your advisory boardslearning programsco-author working groups, and internal corporate events, consider replacing some of these with inflation-neutral virtual engagements. Your customers’ needs have not gone away just because prices are up. If anything, it is more crucial than ever to gather insights from healthcare providers, payers, and patients on current market conditions

Read the rest of the article here to learn more!

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Effective Communication in Virtual Meetings: Stay Pithy - Impetus InSite Tips #4

Learn the value of concise communication in our fourth tip for optimizing virtual meetings. Discover how keeping interactions short and focused can drastically improve engagement and retention in today's fast-paced...

Enhancing Honesty in Feedback: Blinded Questions

Explore our third tip in our series aimed at refining asynchronous virtual meetings. Discover how using blinded questions can significantly minimize bias and enhance the integrity of feedback in virtual...

Streamlining Asynchronous Feedback: Scale Consistency - Impetus InSite Tips #2

Uncover the second crucial tip for optimizing your asynchronous virtual meetings. Learn the importance of scale consistency in survey-style questions on the Impetus InSite Platform to ensure clear and reliable...

Clinical Trial Protocol Conceptualization: A Customer Story

To set their Phase II clinical trial of a novel anti-cancer compound up for success, our client sought early multidisciplinary insights on current unmet needs, as well as feedback on their preclinical...

Mastering Asynchronous Meetings: Open-Ended Questions - Impetus Digital Tip 1

Unlock the potential of asynchronous virtual meetings with the first tip from our "Top 10 Tips for Optimizing Asynchronous Virtual Meetings".

In-person, hybrid, or digital? State of Pharma meetings and events in 2024

We’re diving into the state of pharmaceutical meetings and events in 2024 and–once and for all–put the idea of in-person meetings being superior to rest.

Navigating Regulatory Challenges - Top 10 Most Important Advisor Questions

This quick video covers #9 of our Top 10 Most Important Advisor Questions, shedding light on the complexities of local and national regulatory issues in the Pharma and Life Sciences...

Top-5 Trends in Virtual KOL Engagement

Register now for one of our upcoming webinars (February 26-28)

Engaging with Different Perspectives - Top 10 Most Important Advisor Questions

In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

Patient Advocate Engagement: A Customer Story

Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...